AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22229712
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg meperidine in 10 mL of saline (slow intravenous injection over 2 min)
Trial: 22229712
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of isotonic saline (control group)
Trial: 2239141
Drug: ACTH treatment
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTH treatment (100 units intramuscular, tapered over 12 weeks)
Trial: 26486190
Drug: Postmenopausal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmenopausal hormone therapy (0.625 mg/day conjugated equine estrogens with or without 2.5 mg/day medroxyprogesterone acetate)
Trial: 20080928
Drug: Bupropion sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion sustained release 150 mg b.i.d. (n = 109)
Trial: 19207322
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid gel with preincorporated lidocaine
Trial: 10193975
Drug: Famciclovir 500
RxNorm normalized name: famciclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 500 mg twice daily
Trial: 15018852
Drug: Famciclovir 250
RxNorm normalized name: famciclovir 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 250 mg three times daily
Trial: 15018852
Drug: Aciclovir 800
RxNorm normalized name: Aciclovir 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aciclovir 800 mg five times daily
Trial: 319816
Drug: Naloxone 0.1
RxNorm normalized name: naloxone 0.18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 0.1 mg
Trial: 319816
Drug: Naloxone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 0.2 mg
Trial: 11297596
Drug: Calcium (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1200 mg/day)
Trial: 29496722
Drug: Calcium +
RxNorm normalized name: Calcium + D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium + Vitamin D (1200 mg/day calcium and 1000 IU/day vitamin D3)
Trial: 14744472
Drug: Fluoxetine (FLX)
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (FLX) 20 mg/day
Trial: 14744472
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FLX 20 mg/day and DMI
Trial: 1474165
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil 200 mg oral dose during interdialytic period
Trial: 1474165
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil 200 mg oral dose during intradialytic period
Trial: 15899952
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at doses ranging from 0.18-0.37 mg/kg.wk
Trial: 6231863
Drug: Dilute sulfuric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilute sulfuric acid containing sodium sulfate (solution A)
Trial: 19948449
Drug: Interval debulking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interval debulking surgery after neo-adjuvant chemotherapy
Trial: 2412069
Drug: Ketanserin treatment
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin treatment for 9 months
Trial: 8247951
Drug: Ketanserin therapy
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin therapy
Trial: 7595712
Drug: Cisplatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (20 mg/m2) plus Etoposide (100 mg/m2) (VP)
Trial: 7595712
Drug: Cisplatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (20 mg/m2), Ifosfamide (1.2 g/m2), and Etoposide (75 mg/m2) (VIP)
Trial: 2135137
Drug: GaAlAs laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GaAlAs laser diode treatment (active group)
Trial: 27956455
Drug: Annual oral
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual oral azithromycin treatment of the entire community
Trial: 21829748
Drug: rDEN1Δ30 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rDEN1Δ30 vaccine (2 doses, subcutaneous)
Trial: 9572698
Drug: Lidocaine/prilocaine cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/prilocaine cream 5% (n = 64)
Trial: 7972311
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (200 ml at 0, 2, 4, 8 and 12 h)
Trial: 26133944
Drug: HA +
RxNorm normalized name: PNV-DHA + Docusate Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA + CS injection
Trial: 15933223
Drug: Tdap vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap vaccine (0.5-mL intramuscular dose)
Trial: 15933223
Drug: Td vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Td vaccine (Td)
Trial: 12534409
Drug: Baclofen 40
RxNorm normalized name: baclofen 40,000 MCG per 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen 40 mg p.o.
Trial: 2903059
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg terfenadine
Trial: 1678220
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg terfenadine
Trial: 6781588
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with minimal bandage
Trial: 28578210
Drug: Vaccine refusal
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine refusal vignette
Trial: 28578210
Drug: Vaccine delay
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine delay vignette
Trial: 14990647
Drug: CCI-779 (25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCI-779 (25, 75, or 250 mg weekly as a 30-minute intravenous infusion)
Trial: 9184576
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immune globulin infusions (2 g/kg)
Trial: 29781043
Drug: 4 day
RxNorm normalized name: Ponvory 14 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 day course of antibiotics (Group 1)
Trial: 29781043
Drug: 7 day
RxNorm normalized name: ZonaCort 7 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 day course of antibiotics (Group 2)
Trial: 12817155
Drug: Citalopram (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20-40 mg/day)
Trial: 7937278
Drug: Aconiazide tablets
RxNorm normalized name: Aconiazide
DrugBank: Aconiazide (DB17731)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aconiazide tablets 650 mg (containing isoniazid 300 mg)
Trial: 16175328
Drug: 2 percent
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL GEL [The Keeps ETHANOL 62 percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 percent diltiazem ointment
Trial: 11337622
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment with early mobilization using a hyperextension brace (n = 47)
Trial: 20350955
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 or 15 mg
Trial: 8249562
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml epidural blood patch (EBP)
Trial: 8249562
Drug: 10-15 ml
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-15 ml epidural blood patch (EBP)
Trial: 8249562
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml and 10-15 ml epidural blood patch (EBP)
Trial: 29870578
Drug: GSK2330672 (10-180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2330672 (10-180 mg)
Trial: 23635914
Drug: Lorazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1 to 1.5 mg) intravenously
Trial: 19277410
Drug: DAWN AC
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAWN AC computer-assisted dosage program
Trial: 18317605
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive with estriol (group 2)
Trial: 18317605
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive without estriol (group 1)
Trial: 15078001
Drug: Ertapenem 1
RxNorm normalized name: ertapenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem 1 g daily
Trial: 15164963
Drug: Piperacillin-tazobactam 3.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam 3.375 g Q6H
Trial: 7873470
Drug: Quinapril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril treatment for 20 weeks
Trial: 2450255
Drug: Enoximone (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (150 mg t.d.s.)
Trial: 2450255
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg t.d.s.)
Trial: 29299520
Drug: Inhalation lavender
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhalation lavender aromatherapy
Trial: 25801891
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (4000 IU, orally given as four gel capsules of 1000 IU)
Trial: 20542923
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg TC-1734 (AZD3480)
Trial: 17645482
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg b.i.d.
Trial: 10200896
Drug: Propranolol (PROP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (PROP, without ISA, 160 mg q.d.)
Trial: 8383518
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg (R)-atenolol
Trial: 8383518
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg (S)-atenolol
Trial: 31978010
Drug: Sodium benzoate
RxNorm normalized name: Sodium Benzoate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium benzoate (400 mg/kg loading dose followed by 200 mg·kg·day maintenance for 5 days)
Trial: 31978010
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy with placebo
Trial: 31353457
Drug: MDZ-NS 5
RxNorm normalized name: NS-2
DrugBank: Reproxalap (DB16688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDZ-NS 5 mg (single dose)
Trial: 31353457
Drug: MDZ-NS 5
RxNorm normalized name: NS-2
DrugBank: Reproxalap (DB16688)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDZ-NS 5 mg (second dose if needed)
Trial: 17653742
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine (100 mg)
Trial: 17653742
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine (50 mg)
Trial: 11932297
Drug: GH (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH (0.06 mg/kg.d)
Trial: 11932297
Drug: GH (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH (0.03 mg/kg.d)
Trial: 8554838
Drug: Progesterone pessaries
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone pessaries (400 mg twice a day)
Trial: 21063906
Drug: Corn gluten
RxNorm normalized name: AMINO ACIDS, CORN GLUTEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn gluten meal (CGM) at varying concentrations (0 to 200 g kg⁻¹)
Trial: 25411976
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori eradication therapy
Trial: 12646971
Drug: Methylprednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (10 mg/kg)
Trial: 10883413
Drug: IVIG-L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG-L
Trial: 9179659
Drug: UFT adjuvant
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT adjuvant therapy (1:4 mixture of tegafur and uracil)
Trial: 9179659
Drug: Nonadjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvant therapy
Trial: 1490666
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) alone, 2.6 IU/m2 body surface area daily
Trial: 1490666
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) alone, increased dose to 3.4 IU/m2 daily
Trial: 1490666
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with rhGH (3.4 IU/m2 daily) and reduced oxandrolone (0.05 mg/kg daily)
Trial: 3966331
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg flecainide
Trial: 14703955
Drug: FTY (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY (0.25 - 3.5 mg)
Trial: 14767029
Drug: FTY (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY (3.5 mg)
Trial: 30075578
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg atorvastatin (conventional-dose), n=12
Trial: 30075578
Drug: 40-80 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-80 mg atorvastatin (intensive-dose), n=12
Trial: 22992307
Drug: Protein pulse
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein pulse feeding (PD group, n=30), 72% of dietary protein (1.31 g/kg weight/d on average) consumed in one meal at noon.
Trial: 16821426
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atenolol and midodrine
Trial: 16821426
Drug: Atenolol, Midodrine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, Midodrine, and their combination
Trial: 15228175
Drug: Standard Parent-Child
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Parent-Child Interaction Therapy (STD)
Trial: 15228175
Drug: Abbreviated Parent-Child
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abbreviated Parent-Child Interaction Therapy (ABB)
Trial: 12699020
Drug: No-treatment waitlist
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment waitlist control group (WL)
Trial: 23313462
Drug: First-generation antipsychotics
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotics
Trial: 29744871
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) dexketoprofen and metoclopramide
Trial: 12567365
Drug: Noncontact normothermic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncontact normothermic wound therapy (Warm‐UP; Augustine Medical Inc.) applied for 1 hour 3 times daily until healing or 12 weeks.
Trial: 10598606
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg rapacuronium
Trial: 14576536
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg succinylcholine
Trial: 1858703
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg valine.kg body wt‐1.d‐1 with 80 mg leucine.kg‐1.d‐1
Trial: 1858703
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg valine.kg body wt‐1.d‐1 with 40 mg leucine.kg‐1.d‐1
Trial: 6863097
Drug: Metoprolol (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (7 mg)
Trial: 29053410
Drug: Low-dose exercise
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose exercise (8 kcal/kg of body weight per week)
Trial: 29053410
Drug: High-dose exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose exercise (14 kcal/kg of body weight per week)
Trial: 29053410
Drug: Moderate-intensity exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity exercise (both doses)
Trial: 26598423
Drug: Tolvaptan 45
RxNorm normalized name: tolvaptan 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 45 mg per day
Trial: 26562086
Drug: Psychoanalytic Child
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoanalytic Child Therapy (PaCT); approximately 20 psychotherapy sessions in various settings (parent-child, child-alone, parent-alone).
Trial: 19671217
Drug: tDCS (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tDCS (1 mA current strength, five treatment sessions, active or sham, given on alternate days)
Trial: 7852133
Drug: Pilocarpine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine 2.5 mg, 5.0 mg, and 10.0 mg tablets three times a day for 12 weeks (dose-titration study)
Trial: 7852133
Drug: Pilocarpine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine 5.0 mg and 10.0 mg tablets three times a day for 12 weeks (fixed-dose study)
Trial: 7852133
Drug: Placebo (fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (fixed-dose study)
Trial: 30405296
Drug: Impaired homocysteine
RxNorm normalized name: mecysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impaired homocysteine metabolism group (IHM, n=30)
Trial: 30405296
Drug: Normal homocysteine
RxNorm normalized name: mecysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal homocysteine metabolism group (NHM, n=10)
Trial: 26953629
Drug: LCPT (once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCPT (once-daily extended-release tacrolimus tablets)
Trial: 26953629
Drug: Tac BID
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tac BID (twice-daily tacrolimus capsules)
Trial: 24300782
Drug: Somatropin (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin (0.03 mg/kg/day)
Trial: 21512661
Drug: (131)I treatment
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (131)I treatment
Trial: 12030955
Drug: Essential fatty
RxNorm normalized name: essential fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential fatty acids (gamma-linolenic acid 1.6 g, eicosapentaenoic acid 270 mg, docosahexaenoic acid 45 mg per day)
Trial: 27517654
Drug: Prasugrel (20mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (20mg loading dose, followed by 5mg maintenance dose daily)
Trial: 27517654
Drug: Clopidogrel (300mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300mg loading dose, followed by 75mg maintenance dose daily)
Trial: 19567517
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZOL) 5 mg
Trial: 15716709
Drug: Depressor therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depressor therapy (started ≤ 24 hours post-ictus)
Trial: 15716709
Drug: Therapy (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy (both pressor and depressor)
Trial: 9275461
Drug: 10mg mifepristone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10mg mifepristone daily
Trial: 9275461
Drug: 20mg mifepristone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20mg mifepristone daily
Trial: 21508850
Drug: Other antipsychotics
RxNorm normalized name: Other antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antipsychotics
Trial: 30098152
Drug: Anlotinib (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anlotinib (12 mg/d)
Trial: 400806
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg dapsone daily
Trial: 400806
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg dapsone and 600 mg rifampicin daily for 6 months
Trial: 26395085
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (50 mg/kg bolus followed by 15 mg/kg/h infusion)
Trial: 21236344
Drug: exemestane (EXE)
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: exemestane (EXE) 25 mg daily and celecoxib (CXB) 400 mg twice daily (group A)